5 Key Takeaways

• 1

  In 2026, AI will evolve from a time-saving tool to a critical component in research and development, aiding in hypothesis generation and experiment design.

• 2

  The success in slowing Huntington's disease will drive increased research into other repeat expansion disorders, necessitating broader use of long-read sequencing.

• 3

  More nations will invest in population-specific genomic projects, enhancing precision medicine and addressing the genetic diversity gap in healthcare.

• 4

  AI-guided platforms will transform early biologics pipelines by merging diverse datasets to identify disease targets more effectively and efficiently.

• 5

  Digital twins are expected to become mainstream in clinical development, supported by evolving regulatory frameworks and a focus on patient-centric trials.